Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:09 PM
Ignite Modification Date:
2025-12-24 @ 2:09 PM
NCT ID:
NCT01582295
Eligibility Criteria:
Inclusion Criteria:
* Relapsed/Refractory Multiple Myeloma
* Skeletal lesions suggestive of bone involvement
* Must have received at least 2 lines of prior systemic therapy for the treatment of multiple myeloma
* Must have received prior treatment with a proteasome inhibitor
* Agree to use medically accepted barrier method of contraception
* Not a candidate for ASCT, has declined the option or has relapsed after prior ASCT
Exclusion Criteria:
* Pregnant or breastfeeding
* Has received radiotherapy to thoracic cavity or GI tract (within 3 months of first dose of study drug), bone or brain metastasis (within 14 days of first dose) or any other site (within 28 days)
* Has received any other investigational agent within 28 days
* Primary brain tumor
* Uncontrolled, significant intercurrent or recent illness
* Cardiovascular disorder(s)
* Gastrointestinal disorder(s)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01582295
Study Brief:
Protocol Section:
NCT01582295